Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of a Nitric Oxide Synthase Inhibitor on GLP-2 Mediated Intestinal Lipoprotein Release

NCT03534661 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03534661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03534661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of a Nitric Oxide Synthase Inhibitor on GLP-2 Mediated Intestinal Lipoprotein Release
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Completed
Start date
September 27, 2017
Completion date
March 20, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias